---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-050925"
form_type: "8-K"
ticker: "ELDN"
cik: "0001404281"
company_name: "Eledon Pharmaceuticals, Inc."
filed_at: "2023-10-02T23:59:59+00:00"
generated_at: "2026-06-10T06:19:38.899765+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Eledon Pharmaceuticals appoints Dr. Allan Douglas Kirk to board of directors

## Summary
- Board expands from 8 to 9 directors; Dr. Kirk effective Oct 2, 2023.
- Determined independent under Nasdaq rules; will serve on Science and Technology Committee.
- Annual cash retainers: $42,000 for board service, $7,875 for committee service.
- Granted option for 150,437 shares at market price on Oct 2, 2023; vests over 2 years.
- Enters standard indemnification agreement for directors.

## SEC filing metadata
- accession: 0000950170-23-050925
- form_type: 8-K
- ticker: ELDN
- cik: 0001404281
- company_name: Eledon Pharmaceuticals, Inc.
- filed_at: 2023-10-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1404281/000095017023050925/0000950170-23-050925-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1404281/000095017023050925/eldn-20230929.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-050925
- JSON: https://secwatch.observer/filing/0000950170-23-050925.json
- Plain text: https://secwatch.observer/filing/0000950170-23-050925.txt

## Key facts
- Executive change
  Allan Douglas Kirk was appointed as Director at Eledon Pharmaceuticals, Inc..
  - Action: appointed
  - Role: Director
  source text: On September 29, 2023, Allan Douglas Kirk, MD, PhD, FACS, was appointed to the board of directors (the “Board”) of Eledon Pharmaceuticals, Inc., (“Eledon”), effective October 2, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1404281/000095017023050925/0000950170-23-050925-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.